{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:36:40Z","timestamp":1790282200520,"version":"4.1.0"},"reference-count":41,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Intensive Care Society"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Intravenous fluid therapy is a ubiquitous intervention for the management of patients with sepsis, however excessive cumulative fluid balance has been shown to result in worse outcomes. Hyperoncotic albumin is presented in low volumes, is an effective resuscitation fluid and may have effects beyond plasma volume expansion alone. This systematic review aimed to assess the efficacy, safety and effectiveness of hyperoncotic albumin solutions in the management of sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We searched four databases and two trial registries for controlled clinical trials of hyperoncotic albumin for management of sepsis. Review outcomes were mortality, need for renal replacement therapy, cumulative-fluid balance, and need for organ support. We used methods guided by the Cochrane Handbook for reviews of clinical interventions. Studies were assessed using Cochrane\u2019s Risk of Bias 2 tool. We performed pairwise meta-analysis where possible. Certainty of evidence was assessed using GRADE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We included six trials; four (2772 patients) were meta-analysed. Most studies had moderate or high risk of bias. There was no significant difference in 28-day mortality for septic patients receiving hyperoncotic albumin compared to other intravenous fluids (OR 0.95, [95% CI: 0.8\u20131.12]); in patients with septic shock (2013 patients) there was a significant reduction (OR 0.82 [95% CI: 0.68\u20130.98]). There was no significant difference in safety outcomes. Hyperoncotic albumin was associated with variable reduction in early cumulative fluid balance and faster resolution of shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>There is no good-quality evidence to support the use of hyperoncotic albumin in patients with sepsis, but it may reduce short-term mortality in the sub-groups with septic shock. It appears safe in terms of need for renal replacement therapy and is associated with reduced early cumulative fluid balance and faster resolution of shock. Larger, better quality randomised controlled trials in patients with septic shock may enhance the certainty of these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Review registration:<\/jats:title>\n                    <jats:p>PROSPERO ref: CRD42021150674<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17511437241259437","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:59:55Z","timestamp":1718845195000},"page":"308-318","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["The efficacy, safety and effectiveness of hyperoncotic albumin solutions in patients with sepsis: A systematic review and meta-analysis"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-480X","authenticated-orcid":false,"given":"Jonathan","family":"Bannard-Smith","sequence":"first","affiliation":[{"name":"Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK"},{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elrakhawy","sequence":"additional","affiliation":[{"name":"North West School of Intensive Care Medicine, NHS Health Education England Northwest, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3972-5733","authenticated-orcid":false,"given":"Gill","family":"Norman","sequence":"additional","affiliation":[{"name":"NIHR Innovation Observatory, Population Health Sciences Institute, Newcastle University, Newcastle-upon-Tyne, UK"},{"name":"Evidence Synthesis Group, Population Health Sciences Institute, Newcastle University, Newcastle-upon-Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon","family":"Owen","sequence":"additional","affiliation":[{"name":"Swansea University Medical School, Faculty of Medicine, Health and Life Science, Swansea University, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Felton","sequence":"additional","affiliation":[{"name":"Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK"},{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3309-0164","authenticated-orcid":false,"given":"Paul","family":"Dark","sequence":"additional","affiliation":[{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK"},{"name":"Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Greater Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"bibr1-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"bibr2-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2157-z"},{"key":"bibr3-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002255"},{"key":"bibr4-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181feeb15"},{"key":"bibr5-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0970-1"},{"key":"bibr6-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000219"},{"key":"bibr7-17511437241259437","first-page":"122","volume":"17","author":"Bannard-Smith J","year":"2015","journal-title":"Crit Care Resusc"},{"key":"bibr8-17511437241259437","first-page":"257","volume":"22","author":"Bihari S","year":"2020","journal-title":"Crit Care Resusc"},{"key":"bibr9-17511437241259437","volume":"277","author":"Iglesias J","year":"1999","journal-title":"Am J Physiol"},{"key":"bibr10-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-827X(99)00082-8"},{"key":"bibr11-17511437241259437","volume":"2011","author":"Roberts I","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr12-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181ffe217"},{"key":"bibr13-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1186\/cc6812"},{"key":"bibr14-17511437241259437","volume-title":"The efficacy and safety of hyperoncotic human albumin solution in patients with sepsis: a systematic review and meta-analysis","author":"Bannard-Smith J","year":"2021"},{"key":"bibr15-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.6.1644"},{"key":"bibr16-17511437241259437","volume":"366","author":"Sterne JAC","year":"2019","journal-title":"BMJ"},{"key":"bibr17-17511437241259437","volume-title":"Cochrane handbook for systematic reviews of interventions (updated February 2021)","author":"Higgins JPT","year":"2021"},{"key":"bibr18-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135"},{"key":"bibr19-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.12"},{"key":"bibr20-17511437241259437","author":"Deeks J","year":"2010","journal-title":"Statistical algorithms in Review Manager 5"},{"key":"bibr21-17511437241259437","volume-title":"GRADE handbook for grading quality of evidence and strength of recommendations","author":"Sch\u00fcnemann H","year":"2013"},{"key":"bibr22-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908053410603"},{"key":"bibr23-17511437241259437","first-page":"655","volume":"72","author":"Palumbo D","year":"2006","journal-title":"Minerva Anestesiol"},{"key":"bibr24-17511437241259437","volume":"8","author":"Geoffroy H","year":"2018","journal-title":"Ann Intensive Care"},{"key":"bibr25-17511437241259437","volume":"23","author":"Kongsayreepong S","year":"2019","journal-title":"Crit Care"},{"key":"bibr26-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305727"},{"key":"bibr27-17511437241259437","volume":"37","author":"Charpentier J","year":"2011","journal-title":"Intensive Care Med"},{"key":"bibr28-17511437241259437","first-page":"1622","volume":"56","author":"Dolecek M","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"bibr29-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.03.043"},{"key":"bibr30-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280502"},{"key":"bibr31-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5253-2"},{"key":"bibr32-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0702-y"},{"key":"bibr33-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204242"},{"key":"bibr34-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04211-2"},{"key":"bibr35-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070716"},{"key":"bibr36-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1177\/08850666231170778"},{"key":"bibr37-17511437241259437","doi-asserted-by":"publisher","DOI":"10.2174\/15748863113089990046"},{"key":"bibr38-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-015888"},{"key":"bibr39-17511437241259437","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04921-y"},{"key":"bibr40-17511437241259437","unstructured":"Pesenti A. ALBumin Italian outcome septic shock -BALANCED trial (ALBIOSS-BALANCED), https:\/\/clinicaltrials.gov\/study\/NCT03654001 (2021, accessed 10 November 2023)."},{"key":"bibr41-17511437241259437","unstructured":"Sang-Min K. Albumin and crystalloid administration in septic shock (ALCAMIST), https:\/\/clinicaltrials.gov\/study\/NCT05148286 (2021, accessed 10 November 2023)."}],"container-title":["Journal of the Intensive Care Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17511437241259437","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17511437241259437","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17511437241259437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:55:15Z","timestamp":1777460115000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17511437241259437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1177\/17511437241259437"],"URL":"https:\/\/doi.org\/10.1177\/17511437241259437","relation":{},"ISSN":["1751-1437"],"issn-type":[{"value":"1751-1437","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,19]]}}}